What is your name and where are you from?

I’m Stanford Chimutimunzeve from Zimbabwe

When did you join the ACTG? 

2005

Why did you get involved with the ACTG, and what are some of the things you’ve done as a member?

I’m passionate about the search for an HIV treatment that is free from side effects. I need to push for cure research and will not leave this battle until it is over. I have done many things as a member: I was a co-chair of the Community Scientific Subcommittee, was the community representative to the Inflammation Transformative Science Group, and I am the community rep on various protocols including A5263 and A5356. I’m also on the CAB for sex workers in Zimbabwe and have been actively involved in community mobilization for research education in my community. 

Describe your community.

Zimbabwe has an HIV prevalence of around 13% among the 15-49 age group. We are experiencing high rates of new infections among young women. There are more females living with HIV compared to males. We’re also noticing an increase in the rate of STIs among the15-35 age group. Currently, the national AIDS council is supporting underrepresented key populations such as sex workers, youth, and MSM. MSM are stigmatized in our community. Grandparents—especially grandmothers—have the burden of orphan care. PEPFAR is running a treat-all program in my community. 

What are the most important treatment issues to your community?

Fighting drug-drug interactions for people aging with HIV. Bringing viral hepatitis trials to my community. Addressing complications associated with HIV and long-term ART. Paving the way for cure trials in research limited settings. Ending TB in research limited settings. 

How do you want your work in the ACTG to be remembered?

If I mentor lots of people, then my impact will be multiplied and my work will be remembered.. 

What are your future hopes for the ACTG and HIV research?

I hope the ACTG becomes the leading treatment research institution in the whole world.